← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
BIII
Black Spade Acquisition III Co
Valuation N/A
Financial Services
Price$10.06
Model IV—
P/IV—
Limited data — see page
BILI
Bilibili Inc.
Valuation N/A
Technology Risk 37 · Moderate
Price$15.46
Model IV—
P/IV—
Limited data — see page
BIOA
BioAge Labs, Inc.
Valuation N/A
Healthcare Risk 33 · Moderate
Price$8.49
Model IV—
P/IV—
Market implies +48.7%/yr vs model +15.0% · above model
BIOX
Bioceres Crop Solutions Corp.
Valuation N/A
Basic Materials Risk 31 · Moderate
Price$0.42
Model IV—
P/IV—
Limited data — see page
BIP
Brookfield Infrastructure Partners L.P.
Valuation N/A
Industrials Risk 31 · Moderate
Price$36.88
Model IV—
P/IV—
Limited data — see page
BIPH
Brookfield Infrastructure Partners L.P.
Valuation N/A
Industrials Risk 26 · Moderate
Price$15.66
Model IV—
P/IV—
Limited data — see page
BIPI
Brookfield Infrastructure Partners L.P.
Valuation N/A
Industrials Risk 26 · Moderate
Price$16.39
Model IV—
P/IV—
Limited data — see page
BIPJ
Brookfield Infrastructure Partners L.P.
Valuation N/A
Industrials Risk 27 · Moderate
Price$23.98
Model IV—
P/IV—
Limited data — see page
BIRD
Allbirds, Inc.
Valuation N/A
Consumer Cyclical Risk 34 · Moderate
Price$2.51
Model IV—
P/IV—
Market implies +17.7%/yr vs model +2.0% · above model
BIRK
Birkenstock Holding plc
Valuation N/A
Consumer Cyclical Risk 66 · High
Price$31.13
Model IV—
P/IV—
Limited data — see page
BIT
BlackRock Multi-Sector Income Trust
Valuation N/A
Unknown
Price$11.72
Model IV—
P/IV—
Limited data — see page
BITB
Bitwise Bitcoin ETF
Valuation N/A
Financial Services Risk 51 · Elevated
Price$41.94
Model IV—
P/IV—
Limited data — see page
BITW
Bitwise 10 Crypto Index ETF
Valuation N/A
Financial Services Risk 32 · Moderate
Price$51.90
Model IV—
P/IV—
Limited data — see page
BIVI
BIOVIE INC.
Valuation N/A
Healthcare Risk 29 · Moderate
Price$1.93
Model IV—
P/IV—
Limited data — see page
BIXI
Bitcoin Infrastructure Acquisition Corp Ltd
Valuation N/A
Financial Services
Price$10.08
Model IV—
P/IV—
Limited data — see page
BIYA
Baiya International Group Inc.
Valuation N/A
Technology Risk 30 · Moderate
Price$2.22
Model IV—
P/IV—
Market implies -50.0%/yr vs model +7.8% · below model
BJDX
Bluejay Diagnostics, Inc.
Valuation N/A
Healthcare Risk 30 · Moderate
Price$0.90
Model IV—
P/IV—
Market implies +2.0%/yr vs model +15.0% · below model
BKHA
Black Hawk Acquisition Corp
Valuation N/A
Healthcare Risk 37 · Moderate
Price$11.99
Model IV—
P/IV—
Limited data — see page
BKHAR
Black Hawk Acquisition Corp
Valuation N/A
Healthcare Risk 43 · Elevated
Price$1.30
Model IV—
P/IV—
Limited data — see page
BKKT
Bakkt, Inc.
Valuation N/A
Financial Services Risk 38 · Moderate
Price$8.18
Model IV—
P/IV—
Market implies -50.0%/yr vs model +50.0% · below model
BKNG
Booking Holdings Inc.
Valuation N/A
Industrials Risk 58 · Elevated
Price$173.92
Model IV—
P/IV—
Market implies -50.0%/yr vs model +23.4% · below model
BKSY
BlackSky Technology Inc.
Valuation N/A
Technology Risk 46 · Elevated
Price$20.61
Model IV—
P/IV—
Market implies +26.1%/yr vs model +33.0% · below model
BKT
BLACKROCK INCOME TRUST, INC.
Valuation N/A
Unknown
Price$9.94
Model IV—
P/IV—
Limited data — see page
BLDP
Ballard Power Systems Inc.
Valuation N/A
Technology Risk 37 · Moderate
Price$2.16
Model IV—
P/IV—
Limited data — see page
BLFS
BIOLIFE SOLUTIONS INC
Valuation N/A
Healthcare Risk 31 · Moderate
Price$34.95
Model IV—
P/IV—
Market implies +51.7%/yr vs model +2.0% · above model
BLIV
BeLive Holdings
Valuation N/A
Technology Risk 51 · Elevated
Price$2.25
Model IV—
P/IV—
Limited data — see page
BLND
Blend Labs, Inc.
Valuation N/A
Technology Risk 40 · Elevated
Price$1.45
Model IV—
P/IV—
Market implies +24.2%/yr vs model +2.0% · above model
BLNE
Beeline Holdings, Inc.
Valuation N/A
Financial Services Risk 51 · Elevated
Price$1.03
Model IV—
P/IV—
Market implies +18.3%/yr vs model +2.0% · above model
BLRK
Bluerock Acquisition Corp.
Valuation N/A
Financial Services
Price$10.12
Model IV—
P/IV—
Limited data — see page
BLRX
BioLineRx Ltd.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$2.51
Model IV—
P/IV—
Limited data — see page
BLSH
Bullish
Valuation N/A
Financial Services Risk 33 · Moderate
Price$37.62
Model IV—
P/IV—
Limited data — see page
BLTE
BELITE BIO, INC
Valuation N/A
Healthcare Risk 38 · Moderate
Price$173.79
Model IV—
P/IV—
Limited data — see page
BLUW
Blue Water Acquisition Corp. III
Valuation N/A
Financial Services
Price$10.37
Model IV—
P/IV—
Limited data — see page
BLW
BLACKROCK Ltd DURATION INCOME TRUST
Valuation N/A
Unknown
Price$12.28
Model IV—
P/IV—
Limited data — see page
BLX
FOREIGN TRADE BANK OF LATIN AMERICA, INC.
Valuation N/A
Financial Services Risk 32 · Moderate
Price$54.12
Model IV—
P/IV—
Limited data — see page
BLZR
Trailblazer Acquisition Corp.
Valuation N/A
Financial Services
Price$10.21
Model IV—
P/IV—
Limited data — see page
BMA
Macro Bank Inc.
Valuation N/A
Financial Services Risk 52 · Elevated
Price$77.02
Model IV—
P/IV—
Limited data — see page
BME
BlackRock Health Sciences Trust
Valuation N/A
Unknown
Price$44.22
Model IV—
P/IV—
Limited data — see page
BMEA
Biomea Fusion, Inc.
Valuation N/A
Healthcare Risk 37 · Moderate
Price$1.74
Model IV—
P/IV—
Limited data — see page
BMEZ
BlackRock Health Sciences Term Trust
Valuation N/A
Unknown
Price$16.45
Model IV—
P/IV—
Limited data — see page
BMGL
Basel Medical Group Ltd
Valuation N/A
Healthcare Risk 27 · Moderate
Price$4.58
Model IV—
P/IV—
Limited data — see page
BMHL
Bluemount Holdings Ltd
Valuation N/A
Financial Services Risk 27 · Moderate
Price$5.30
Model IV—
P/IV—
Limited data — see page
BMM
Blue Moon Metals Inc.
Valuation N/A
Basic Materials
Price$5.46
Model IV—
P/IV—
Limited data — see page
BMN
BlackRock 2037 Municipal Target Term Trust
Valuation N/A
Unknown
Price$24.58
Model IV—
P/IV—
Limited data — see page
BMNR
BITMINE IMMERSION TECHNOLOGIES, INC.
Valuation N/A
Financial Services Risk 34 · Moderate
Price$25.03
Model IV—
P/IV—
Market implies +114.6%/yr vs model +15.0% · above model
BMO
BANK OF MONTREAL /CAN/
Valuation N/A
Financial Services Risk 33 · Moderate
Price$174.88
Model IV—
P/IV—
Limited data — see page
BMR
Beamr Imaging Ltd.
Valuation N/A
Technology Risk 27 · Moderate
Price$1.35
Model IV—
P/IV—
Market implies +56.3%/yr vs model +2.0% · above model
BN
BROOKFIELD Corp /ON/
Valuation N/A
Real Estate
Price$37.61
Model IV—
P/IV—
Limited data — see page
BNAI
Brand Engagement Network Inc.
Valuation N/A
Technology Risk 42 · Elevated
Price$8.03
Model IV—
P/IV—
Market implies +80.5%/yr vs model +15.0% · above model
BNBX
BNB PLUS CORP.
Valuation N/A
Industrials Risk 37 · Moderate
Price$0.16
Model IV—
P/IV—
Market implies +3.1%/yr vs model +2.0% · in line
BNC
CEA Industries Inc.
Valuation N/A
Basic Materials Risk 40 · Elevated
Price$5.27
Model IV—
P/IV—
Market implies +69.9%/yr vs model +0.0% · above model
BNH
BROOKFIELD Corp /ON/
Valuation N/A
Real Estate
Price$14.86
Model IV—
P/IV—
Limited data — see page
BNJ
BROOKFIELD Corp /ON/
Valuation N/A
Real Estate
Price$14.60
Model IV—
P/IV—
Limited data — see page
BNKK
BONK, INC.
Valuation N/A
Consumer Defensive Risk 28 · Moderate
Price$1.39
Model IV—
P/IV—
Market implies +53.5%/yr vs model +2.0% · above model
BNO
United States Brent Oil Fund, LP
Valuation N/A
Financial Services Risk 32 · Moderate
Price$61.37
Model IV—
P/IV—
Limited data — see page
BNR
Burning Rock Biotech Ltd
Valuation N/A
Healthcare
Price$12.28
Model IV—
P/IV—
Limited data — see page
BNRG
Brenmiller Energy Ltd.
Valuation N/A
Industrials Risk 49 · Elevated
Price$3.16
Model IV—
P/IV—
Market implies +28.8%/yr vs model +2.0% · above model
BNS
BANK OF NOVA SCOTIA
Valuation N/A
Financial Services Risk 41 · Elevated
Price$93.45
Model IV—
P/IV—
Limited data — see page
BNTX
BioNTech SE
Valuation N/A
Healthcare Risk 41 · Elevated
Price$96.73
Model IV—
P/IV—
Limited data — see page
BOBS
Bob's Discount Furniture, Inc.
Valuation N/A
Consumer Cyclical Risk 51 · Elevated
Price$15.85
Model IV—
P/IV—
Limited data — see page